Darius Kharabi serves as Executive at Kala Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Darius Kharabi has executed 11 insider transactions totaling $52.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 22, 2025 involved selling 20,806 shares valued at $17.3K.
Darius Kharabi currently holds 41,760 shares of Kala Pharmaceuticals, Inc. (KALA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Darius Kharabi has been a net seller of KALA stock. They have purchased $0 and sold $52.5K worth of shares.
Darius Kharabi's most recent insider trade was on Oct 22, 2025, when they sold 20,806 shares at $0.83 per share.
Get notified when new Form 4 filings are submitted
| $4.75 |
| Discretionary |
| May 31, 2024 | KALA | $1.4K | Sale | 231 | $6.09 | Discretionary |
| Jan 4, 2024 | KALA | $9.3K | Sale | 1,385 | $6.73 | Discretionary |
| Jan 4, 2024 | KALA | $0 | Award | 4,600 | $N/A | Discretionary |
| Jun 22, 2023 | KALA | $0 | Award | 36,847 | $N/A | Discretionary |
| May 31, 2023 | KALA | $0 | Award | 2,648 | $N/A | Discretionary |
| Mar 10, 2023 | KALA | $0 | Award | 6,977 | $N/A | Discretionary |
| Jan 4, 2023 | KALA | $0 | Award | 9,525 | $N/A | Discretionary |
| Feb 15, 2022 | KALA | $0 | Other | 9 | $N/A | Discretionary |
| Nov 15, 2021 | KALA | $0 | Award | 295,657 | $N/A | Discretionary |